Ayurvedic management of pre-Hypertension with a coded drug Ayush-HR

Phase 2

• Conditions: Health Condition 1: I10- Essential (primary) hypertension

• Registration Number: CTRI/2019/09/021266
• Lead Sponsor: CCRAS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients of either sex aged 30-65 years

2.Diagnosed patients of Pre hypertension as per 7th report of JNC

(120-139 mm of Hg SBP and 80-89 mm of Hg DBP)

3.Willing and able to participate for 3 months

Exclusion Criteria

1.Patients who have history of Cardiac Arrhythmia, Acute Coronary Syndrome, Myocardial Infarction, congestive cardiac failure ,Stroke or Severe Arrhythmia in the last 6 months.

2.Essential Hypertension / Secondary hypertension.

3.Patients with concurrent Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2 mg/dl),uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Neurological disorders, Endocrinal disorders, etc.) or Known cases of malignancy

4.Uncontrolled Diabetes Mellitus(HbA1C >8)

5.Women who are planning for conception / pregnant or lactating.

6.H/o hypersensitivity to any of the trial drugs or their ingredients.

7.Patient taking participation in any other clinical trial.

8.Any other condition which the P.I. thinks may jeopardize the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified